Literature DB >> 33418575

Menopausal Hormone Therapy and Health Outcomes: Is Timing Everything?

JoAnn E Manson1,2.   

Abstract

Mesh：

Year:  2021        PMID： 33418575      PMCID： PMC7793222          DOI： 10.1093/clinchem/hvaa286

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  6 in total

1.  Guidelines for counseling postmenopausal women about preventive hormone therapy. American College of Physicians.

Authors: 
Journal:  Ann Intern Med       Date:  1992-12-15       Impact factor: 25.391

2.  The Women's Health Initiative trials of menopausal hormone therapy: lessons learned.

Authors:  JoAnn E Manson; Shari S Bassuk; Andrew M Kaunitz; JoAnn V Pinkerton
Journal:  Menopause       Date:  2020-08       Impact factor: 2.953

3.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

4.  Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.

Authors:  Garnet L Anderson; Marian Limacher; Annlouise R Assaf; Tamsen Bassford; Shirley A A Beresford; Henry Black; Denise Bonds; Robert Brunner; Robert Brzyski; Bette Caan; Rowan Chlebowski; David Curb; Margery Gass; Jennifer Hays; Gerardo Heiss; Susan Hendrix; Barbara V Howard; Judith Hsia; Allan Hubbell; Rebecca Jackson; Karen C Johnson; Howard Judd; Jane Morley Kotchen; Lewis Kuller; Andrea Z LaCroix; Dorothy Lane; Robert D Langer; Norman Lasser; Cora E Lewis; JoAnn Manson; Karen Margolis; Judith Ockene; Mary Jo O'Sullivan; Lawrence Phillips; Ross L Prentice; Cheryl Ritenbaugh; John Robbins; Jacques E Rossouw; Gloria Sarto; Marcia L Stefanick; Linda Van Horn; Jean Wactawski-Wende; Robert Wallace; Sylvia Wassertheil-Smoller
Journal:  JAMA       Date:  2004-04-14       Impact factor: 56.272

5.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

6.  The 2017 hormone therapy position statement of The North American Menopause Society.

Authors: 
Journal:  Menopause       Date:  2017-07       Impact factor: 3.310
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.